Erasca, Inc.
ERASNASDAQHealthcare● Active
$12.87
+$0.90(+7.52%)
Market Cap$4.0B
P/E Ratio—
52W High$24.28
52W Low$1.21
Erasca, Inc. (ERAS) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ERAS · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | ($0.00B) | $0.00B | ($0.00B) | ($0.00B) | ($0.00B) |
| Gross Margin %(computed) | — | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.09B | $0.12B | $0.10B | $0.11B | $0.07B |
| G&A Expenses | $0.04B | $0.04B | $0.04B | $0.03B | $0.02B |
| Total Operating Expenses | $0.13B | $0.18B | $0.14B | $0.24B | $0.12B |
| Operating Income | ($0.13B) | ($0.18B) | ($0.14B) | ($0.25B) | ($0.12B) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.02B | $0.02B | $0.02B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.20B | $0.00B |
| Income Before Tax | ($0.12B) | ($0.16B) | ($0.13B) | ($0.24B) | ($0.12B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.12B) | ($0.16B) | ($0.13B) | ($0.24B) | ($0.12B) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.44 | $-0.69 | $-0.83 | $-1.99 | $-1.03 |
| Wtd Avg Shares | 0.28B | 0.23B | 0.15B | 0.12B | 0.12B |
| EBITDA | ($0.13B) | ($0.15B) | ($0.12B) | ($0.24B) | ($0.12B) |
| EBITDA Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Erasca, Inc. data
About Erasca, Inc. (ERAS) Income Statement
Erasca, Inc. (ERAS) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, ERAS reported revenue of $0.00B, gross profit of ($0.00B) (gross margin —), and net income of ($0.12B) — a net profit margin of —.
Frequently asked questions
ERAS · 4 questionsErasca, Inc. (ERAS) reported revenue of $0.00B for 2025, down —% year-over-year.
ERAS revenueERAS salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08